J&J Forecasts Strong Pharma Growth In 2021, But No COVID-19 Vaccine Update
Data from a high-profile Phase III COVID-19 vaccine trial will be released the first week of February, management said.
You may also be interested in...
Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.
J&J expects its medical device sales to begin growing rapidly by the middle of 2021 as the pandemic subsides.
Moderna has unveiled plans to develop a new booster vaccine, tweaked to meet the threat posed by the South African strain.